Early conversations crucial in the management of type 2 diabetes

IntroDia logo

Preliminary results of the IntroDia™ survey presented at the American Diabetes Association’s (ADA) 74th Scientific Sessions®  show that early conversations have an impact in the management of type 2 diabetes and can impact patient outcomes.


IntroDia™, developed by Boehringer Ingelheim GmbH (BI) and Eli Lilly and Company in partnership with the International Diabetes Federation (IDF), is the largest multinational survey of its kind to date which aims to investigate early conversations between physicians and people living with T2D, and how these conversations may correlate with the individuals’ wellbeing and self-care.

For more information:
Download the press release here
Visit the IntroDia™ website here
 

Watch the IntroDia™ Multimedia Series below

Episode 1

Episode 2

Episode 3